Lisa Gill
Stock Analyst at JP Morgan
(3.59)
# 673
Out of 4,810 analysts
136
Total ratings
50.56%
Success rate
3.22%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $20.86 | +43.82% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $31.84 | +28.77% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $19.13 | -11.13% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $284.82 | -10.12% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $69.20 | +17.05% | 5 | Feb 18, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $173 → $180 | $168.00 | +7.14% | 2 | Feb 4, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $134.78 | +7.58% | 6 | Feb 4, 2025 | |
| COR Cencora | Maintains: Overweight | $289 → $301 | $284.29 | +5.88% | 2 | Jan 24, 2025 | |
| PACS PACS Group | Downgrades: Neutral | $18 | $9.35 | +92.51% | 2 | Dec 17, 2024 | |
| INNV InnovAge Holding | Downgrades: Underweight | $5 | $2.83 | +76.68% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $21.32 | +31.33% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $28 | $24.05 | +16.42% | 4 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $10.91 | +37.49% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.24 | +24.31% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $6.92 | +160.12% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $693.98 | -4.75% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $329.20 | +33.05% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $12.42 | +44.93% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $348.57 | +13.32% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $228.04 | +6.56% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $178.82 | +4.02% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $546 → $559 | $587.06 | -4.78% | 5 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $124.91 | +12.08% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $340.62 | -2.53% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $628 → $631 | $441.17 | +43.03% | 4 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.49 | +122.72% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $5.60 | +60.71% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $4.71 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $6.85 | +16.79% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $65.61 | +26.51% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $63.01 | +55.53% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $24 | $31.34 | -23.42% | 4 | Jun 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $19.53 | - | 4 | Dec 19, 2017 |
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $20.86
Upside: +43.82%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $31.84
Upside: +28.77%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $19.13
Upside: -11.13%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $284.82
Upside: -10.12%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $69.20
Upside: +17.05%
Quest Diagnostics
Feb 4, 2025
Maintains: Neutral
Price Target: $173 → $180
Current: $168.00
Upside: +7.14%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $134.78
Upside: +7.58%
Cencora
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $284.29
Upside: +5.88%
PACS Group
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $9.35
Upside: +92.51%
InnovAge Holding
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $2.83
Upside: +76.68%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $21.32
Upside: +31.33%
Nov 29, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $24.05
Upside: +16.42%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $10.91
Upside: +37.49%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.24
Upside: +24.31%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $6.92
Upside: +160.12%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $693.98
Upside: -4.75%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $329.20
Upside: +33.05%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $12.42
Upside: +44.93%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $348.57
Upside: +13.32%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $228.04
Upside: +6.56%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $178.82
Upside: +4.02%
May 30, 2024
Maintains: Overweight
Price Target: $546 → $559
Current: $587.06
Upside: -4.78%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $124.91
Upside: +12.08%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $340.62
Upside: -2.53%
May 30, 2024
Maintains: Overweight
Price Target: $628 → $631
Current: $441.17
Upside: +43.03%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.49
Upside: +122.72%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $5.60
Upside: +60.71%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $4.71
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $6.85
Upside: +16.79%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $65.61
Upside: +26.51%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $63.01
Upside: +55.53%
Jun 7, 2018
Maintains: Underweight
Price Target: $26 → $24
Current: $31.34
Upside: -23.42%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $19.53
Upside: -